Chiesi starts rare diseases division, ahead of potential Fabry disease filing

cafead

Administrator
Staff member
  • cafead   Feb 18, 2020 at 10:32: AM
via Italian pharma Chiesi has begun a new rare diseases division as it builds towards a potential commercial launch for its Fabry Disease therapy.

article source
 

<